In a move that is viewed as a major step toward developing a secure and portable health information system for all Americans, the U.S. Department of Health and Human Services has awarded the Indiana University School of Medicine a $2.5 million contract to begin a trial implementation of a Nationwide Health Information Network.
Grantees of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have adapted a rapid and accurate new molecular typing strategy and used it to conduct one of the most comprehensive studies of adenoviruses ever performed in the United States.
Acupuncture treatments will be included for the first time in Canada as a supplementary benefit for Medical Services Plan (MSP) premium assistance recipients by April 2008, Health Minister George Abbott announced.
The world’s maternal mortality ratio (the number of maternal deaths per 100 000 live births) is declining too slowly to meet Millennium Development Goal (MDG) 5, which aims to reduce the number of women who die in pregnancy and childbirth by three-quarters by 2015.
Lead is a naturally occurring element that is found everywhere in the environment. Following is the statement by John Bailey, EVP for science cosmetic, toiletry, and fragrance association on campaign for safe cosmetics report on lead in lipstick –
The final numbers are in. The Conversation on Health has ended, with over 12,000 submissions and thousands more people taking part in public forums, providing their ideas on the future of the health system.
Government has invested $2.3 million towards development of a provincewide patient safety learning system based on the success of pilot-testing at two B.C. hospitals, announced Health Minister George Abbott during Canadian Patient Safety Week.
Accentia Biopharmaceuticals announces that it met with the Food and Drug Administration (FDA) on September_26, 2007 for a scheduled pre-Investigational New Drug (pre-IND) meeting on Revimmune™. The FDA has indicated its support for Accentia to submit an IND for a pivotal Phase 3 randomized controlled, multi-center clinical trial of Revimmune, the company’s potential therapeutic for refractory, relapsing-remitting Multiple Sclerosis (MS).
At the Keystone Symposium in Cape Town, the Global HIV Vaccine Enterprise announced the appointment of its first executive director and the opening of a new secretariat in New York City. Dr. Alan Bernstein, founding president of the Canadian Institutes of Health Research, will lead the international alliance of researchers, funders and advocates dedicated to speeding the search for an HIV vaccine.
In the light of growing concerns about the separation of producers and consumers in our food system and the power of big supermarkets, new research funded by Economic and Social Research Council (ESRC) provides valuable insights into the motivations and practices of consumers and producers involved in ‘alternative food’ networks, which include schemes as varied as organic vegetable boxes, community gardens and farm animal adoption.